Deplete, Reprogram, Regenerate

Towards Disease Modifying
Treatments for
Fibroinflammatory Diseases

Our Vision

At FimmCyte, we are driven by the goal of leading innovation. Our most advanced endeavor is on developing targeted solutions to address endometriosis, a chronic disease that has been neglected for too long. Our first-in-class treatments, based on cutting-edge immunotherapy research, represent a disease-modifying approach going beyond traditional therapies.

Innovation at Our Core: We are at the forefront of targeted solutions in women’s health, with a breakthrough immunotherapy platform designed to eliminate diseased tissue without affecting healthy areas. This represents a monumental shift in treating endometriosis and other fibro-inflammatory diseases.

“FimmCyte is redefining the future of healthcare with chronic disease transformers that target not only symptoms but the root cause of diseases.”

Future of Innovation

At FimmCyte, we are redefining the treatment of endometriosis and other chronic fibro-inflammatory diseases with targeted immunotherapy solutions. Our platform leverages the discovery of a specific protein overexpressed in diseased cells, enabling precise elimination of fibrotic tissue while preserving healthy areas.

The FMC2 antibody is a breakthrough therapy designed to recognize a well-established marker of fibrosis. Using a proprietary binding domain, it recruits immune cells to safely and effectively eliminate diseased tissue. With proven antifibrotic effects, FMC2 addresses critical unmet needs in endometriosis and shows promise for treating other fibrotic conditions.

FimmCyte’s innovative technology positions us as a chronic disease transformer, offering targeted therapies that improve outcomes and transform lives worldwide.

Why FimmCyte?

Innovation at Our Core: FimmCyte leads the charge in targeted solutions for women’s health and beyond, with a cutting-edge immunotherapy platform that eliminates diseased tissue without harming healthy cells. This revolutionary approach marks a paradigm shift in treating endometriosis and other fibro-inflammatory diseases.

Our vision extends beyond innovation—we are pioneering first-in-class, disease-modifying treatments to meet the critical needs of a large and underserved market. FimmCyte’s solutions not only tackle chronic conditions but also unlock significant market potential, positioning us as a leader in the biotech landscape.

Transforming Lives

At FimmCyte, patients are at the heart of everything we do. Our innovative therapies are designed to go beyond symptom management, tackling endometriosis and other chronic conditions at their core. By focusing on disease-modifying treatments, we aim to offer patients new hope, lasting relief, and a significantly improved quality of life.

Our commitment to empowering patients drives us to develop targeted solutions that address the root causes of chronic fibro-inflammatory diseases, providing transformative care for millions worldwide.

billion $ <br /> fibrosis market size

year<br /> founded

years combined<br /> experience

patents<br /> filed so far

billion $ <br /> fibrosis market size

patents<br /> filed so far

year<br /> founded

years combined<br /> experience

Get to know our Supporters & Partners

Great solutions require partners, trust, and the opportunity to break new ground in medical research together. A special thank you to our dedicated partners, whose collaboration and expertise help us push the boundaries of innovation every day.

Venture Kick

Discover more about Venture Kick by visiting their website.

USZ Zürich

Explore all about USZ Zürich by visiting their website.

UZH Entrepreneur

Learn all the details about UZH Entrepreneur on their website.

BioInnovation Institute

Explore all about BioInnovation Institute here.

Gebert Rüf Stiftung

Find out more about Gebert Rüf Stiftung on their website.

Innosuisse

Discover more about Innosuisse by visiting their website.

BaseLaunch

Learn all the details about BaseLaunch on their website.

UZH Life

Find out more about UZH Life on their website.

Meet the Innovators

Behind every breakthrough is a team of visionaries. Meet the experts at FimmCyte who are reshaping the future of fibro-inflammatory disease care.

Mohaned Shilaih

Mohaned Shilaih

PhD, CEO

Valentina Vongrad

Valentina Vongrad

PhD, CSO

Maureen Cronin

Maureen Cronin

MD-PhD, CMO

Our Insights

Contact us

We’re excited to hear from you and discuss how we can work together.